Search Within

Robert Motzer

Formats
  1. Journal Article (609)
  2. Meeting Abstract (578)
  3. Book Section (20)
  4. Review (13)
  5. Conference Paper (6)
  6. Correspondence (6)
  7. Guidelines (5)
  8. Research Letter (5)
  9. Editorial (3)
  10. Book Whole (2)
Groups
  1. Department of Medicine (1247)
  2. Genitourinary Oncology Service (1247)
  3. Solid Tumor Oncology Division (1247)
  4. Surgery (290)
  5. Urology (281)
  6. Survivorship Research (253)

More Groups

People
  1. George Bosl (182)
  2. Martin Voss (178)
  3. Darren Feldman (158)
  4. Dean Bajorin (128)
  5. Paul Russo (119)
  6. Joel Sheinfeld (110)

More People

Years
  1. 2025 (30)
  2. 2024 (49)
  3. 2023 (47)
  4. 2022 (64)
  5. 2021 (65)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (448)
  2. Annals of Oncology (81)
  3. BJU International (40)
  4. Cancer (35)
  5. European Journal of Cancer (34)
  6. Clinical Cancer Research (33)

More Publications

Publishers
  1. American Society of Clinical Oncology (451)
  2. Elsevier Science, Inc. (111)
  3. Oxford University Press (111)
  4. Elsevier Inc. (89)
  5. Wiley Blackwell (86)
  6. American Association for Cancer Research (58)

More Publishers

Results (1247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neutrophil-to-lymphocyte ratio in unclassified renal cell carcinoma is associated with clinical outcome and varies between genomic subgroups
    Meeting Abstract

    Marcon, J.; Di Natale, R. G.; Weng, S.; Ghanaat, M.; Silagy, A. W.; Mano, R.; Blum, K. A.; Attalla, K.; Reznik, E.; Carlo, M. I.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • IMmotion151: Updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Rini, B. I.; Atkins, M. B.; Escudier, B.; Powles, T.; McDermott, D. F.; Alekseev, B. Y.; Lee, J. L.; Stroyakovskiy, D.; Suarez Rodriguez, C.; De Giorgi, U.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase 1b/2 umbrella study of investigational immune and targeted combination therapies for patients with advanced renal cell carcinoma (RCC) who progressed on PD-1/L1 and VEGF inhibitors
    Meeting Abstract

    Hammers, H.; Choueiri, T.; Plimack, E.; Rini, B.; Motzer, R.; Yin, L.; Perini, R.; Willemann-Rogerio, J.; Albiges, L.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab for renal cell carcinoma - The authors reply
    Correspondence

    Motzer, R.; Choueiri, T. K.
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma
    Journal Article

    Powles, T.; Choueiri, T. K.; Motzer, R. J.; Jonasch, E.; Pal, S.; Tannir, N. M.; Signoretti, S.; Kaldate, R.; Scheffold, C.; Wang, E.; more...
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • Genitourinary medical oncology expert opinion survey regarding treatment management in the COVID-19 pandemic
    Journal Article

    Sarfaty, M.; Feldman, D. R.; Morris, M. J.; Motzer, R. J.; Rathkopf, D. E.; Regazzi, A. M.; Iyer, G.; Voss, M. H.; Bajorin, D. F.; Rosenberg, J. E.
    Clinical Genitourinary Cancer (2021)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): A phase 1b/2 study
    Journal Article

    Lee, C. H.; Shah, A. Y.; Rasco, D.; Rao, A.; Taylor, M. H.; Di Simone, C.; Hsieh, J. J.; Pinto, A.; Shaffer, D. R.; Girones Sarrio, R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicity (Q-TWiST) for lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma
    Journal Article

    Lee, C. H.; Wan, Y.; Smith, A.; Xie, R.; Motzer, R. J.
    European Urology Open Science (2021)

    Fulltext@MSK | Save
  • Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: Post hoc analysis of a randomized clinical trial
    Journal Article

    Choueiri, T. K.; Larkin, J.; Pal, S.; Motzer, R. J.; Rini, B. I.; Venugopal, B.; Alekseev, B.; Miyake, H.; Gravis, G.; Bilen, M. A.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save
  • Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors
    Journal Article

    Funt, S. A.; McHugh, D. J.; Tsai, S.; Knezevic, A.; O'Donnell, D.; Patil, S.; Silber, D.; Bromberg, M.; Carousso, M.; Reuter, V. E.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save